Quantamental Technologies’s Pfizer PFE Stock Holding History

Quantamental Technologies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,497	Closed	-$1.27M	–	508
2023 Q2	$1.27M	Buy	34,497 +14,575	+73%	+$567K	0.53%	41
2023 Q1	$813K	Buy	19,922 +15,905	+396%	+$687K	0.44%	60
2022 Q4	$206K	Sell	4,017 -23,666	-85%	-$1.13M	0.09%	363
2022 Q3	$1.21M	Buy	+27,683	New	+$1.35M	0.47%	43
2021 Q4	–	Sell	-5,266	Closed	-$226K	–	479
2021 Q3	$226K	Buy	+5,266	New	+$233K	0.15%	233
2021 Q2	–	Sell	-6,385	Closed	-$231K	–	268
2021 Q1	$231K	Buy	+6,385	New	+$227K	0.74%	67
2020 Q3	–	Sell	-6,887	Closed	-$214K	–	345
2020 Q2	$214K	Buy	+6,887	New	+$234K	0.14%	238
2020 Q1	–	Sell	-37,853	Closed	-$1.41M	–	327
2019 Q4	$1.41M	Buy	37,853 +35,088	+1,269%	+$1.25M	0.72%	13
2019 Q3	$94K	Buy	+2,765	New	+$101K	0.03%	762

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's PFE Position: Q3 2023 in Review

Quantamental Technologies sold out of Pfizer (PFE) in Q3 2023, closing a stake of 34,497 shares — an estimated $1.27M sold.

Quantamental Technologies first reported a position in PFE in Q3 2019 and held it in 9 quarters. The position peaked at $1.41M in Q4 2019. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Quantamental Technologies reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Quantamental Technologies sold 34,497 Pfizer shares in Q3 2023, an estimated $1.27M.
Quantamental Technologies first reported a position in Pfizer in Q3 2019 and held it in 9 quarters.
Quantamental Technologies's Pfizer position peaked at $1.41M in Q4 2019.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.